Clinical trials recruiting in Bois-Guillaume, France
4
Recruiting trials
6
Conditions
Phase breakdown
Phase 3 4
Conditions recruiting in Bois-Guillaume, France
| Condition | Trials |
|---|---|
| Obesity | 2 |
| Type 2 Diabetes | 2 |
| Atherosclerosis Cardiovascular Disease | 1 |
| Chronic Kidney Disease | 1 |
| Heart Failure | 1 |
| Obesity or Overweight | 1 |
Recruiting trials in Bois-Guillaume, France
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Common questions
How many clinical trials are recruiting in Bois-Guillaume, France?
4 recruiting trials have at least one study site in Bois-Guillaume, France.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.